首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >A novel mutation at a ligand-binding site of hypoxanthine-guanine phosphoribosyl transferase, p.Y105C (HPRT(HongKong)), in a Chinese teenager with recurrent gouty arthritis.
【24h】

A novel mutation at a ligand-binding site of hypoxanthine-guanine phosphoribosyl transferase, p.Y105C (HPRT(HongKong)), in a Chinese teenager with recurrent gouty arthritis.

机译:中国青少年患有痛风性关节炎的次黄嘌呤-鸟嘌呤磷酸核糖基转移酶p.Y105C(HPRT(HongKong))的配体结合位点的新型突变。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Dear Editor, Hypoxanthine-guaninephosphoribosyl transferase (HPRT1) is a purine salvage enzyme which catalyzes the transfer of the phosphoribosyl moiety of hypoxanthine and guanine to form inosine monophosphate and guanosine monophosphate respectively. Patients with HPRT1 deficiency have been classified into 3 groups: (1) Classic Lesch-Nyhan disease (LND); (2) HPRT1-related neurological dysfunction (HRND); and (3) HPRTl-related hyperuricemia (HRH) . A complete loss of HPRT1 activity will cause LND while a partial loss of HPRT1 activity will result in HRHD and HRH . LND is manifested as childhood-onset severe neurological symptoms including self-mutilating behavior and hyperuricemia. Self-injurious behavior is absent in HRND and HRH patients, however, HRND patients will have neurological symptoms such as dystonia and impaired cognitive disability. We report the molecular investigation, of a Chinese patient with HRH.
机译:尊敬的编辑,次黄嘌呤-鸟嘌呤磷酸核糖基转移酶(HPRT1)是一种嘌呤挽救酶,催化次黄嘌呤和鸟嘌呤的磷酸核糖基部分的转移,分别形成肌苷单磷酸和鸟嘌呤单磷酸。 HPRT1缺乏症患者可分为3组:(1)经典的Lesch-Nyhan病(LND); (2)HPRT1相关的神经功能障碍(HRND); (3)HPRT1相关的高尿酸血症(HRH)。 HPRT1活性的完全丧失将导致LND,而HPRT1活性的部分丧失将导致HRHD和HRH。 LND表现为儿童期发作的严重神经系统症状,包括自残行为和高尿酸血症。 HRND和HRH患者没有自残行为,但是HRND患者会出现神经系统症状,例如肌张力障碍和认知障碍。我们报告了一名中国HRH患者的分子调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号